Mike discusses the unique investment landscape in China, emphasizing the importance of understanding local market dynamics while applying global frameworks. He highlights the potential of contract drug manufacturing organizations, noting their critical role in accelerating innovation for pharmaceutical companies. The conversation also touches on the contrasting characteristics of heavy and light industries, revealing unexpected insights about competitive advantages in these sectors.
